Publication
Water-exchange pharmacokinetic modeling improves DCE-MRI for ROI-based assessment of prostate lesions and of clinically significant prostate cancer.
Zejun Wang, Zhenjie Zang, Yong Li, Zhaoqin Huang, Hui Zhang, Qiang Fu, Ruiliang Bai
Magnetic resonance imagingDec 1, 2026PMID 42674229doi:10.1016/j.mri.2026.110778 Journal ArticleResearch Support, Non-U.S. Gov'tpubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260929-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
PURPOSE: Quantitative multiparametric MRI (mpMRI) is increasingly explored for clinically significant prostate cancer (csPCa) detection; however, the diagnostic value of quantitative dynamic contrast-enhanced (DCE)-MRI in prostate cancer remains controversial. In this study, we aim to evaluate the…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Prostate Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.